184 related articles for article (PubMed ID: 33261584)
1. A genomic-clinicopathologic nomogram for predicting overall survival of hepatocellular carcinoma.
Zhou K; Zhou Q; Cai C
BMC Cancer; 2020 Dec; 20(1):1176. PubMed ID: 33261584
[TBL] [Abstract][Full Text] [Related]
2. A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
Zhang Z; Weng W; Huang W; Wu B; Zhou Y; Zhang J; Deng T; Ye W; Zhang J; Ao J; Zhang Q; Shi K
Aging (Albany NY); 2020 Jun; 12(13):12896-12920. PubMed ID: 32611831
[TBL] [Abstract][Full Text] [Related]
3. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
4. A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
Ni FB; Lin Z; Fan XH; Shi KQ; Ao JY; Wang XD; Chen RC
Clin Chim Acta; 2020 May; 504():88-97. PubMed ID: 32032609
[TBL] [Abstract][Full Text] [Related]
5. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
Lu Z; Sun Z; Liu C; Shi X; Li R; Shao W; Zheng Y; Li Y; Song J
BMC Cancer; 2021 Jun; 21(1):751. PubMed ID: 34187430
[TBL] [Abstract][Full Text] [Related]
7. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
8. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
11. Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
Chen S
DNA Cell Biol; 2021 Feb; 40(2):359-372. PubMed ID: 33290144
[TBL] [Abstract][Full Text] [Related]
12. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
13. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
[TBL] [Abstract][Full Text] [Related]
14. m
Li W; Liu J; Ma Z; Zhai X; Cheng B; Zhao H
Dis Markers; 2021; 2021():8859590. PubMed ID: 34234878
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.
Yu B; Liang H; Ye Q; Wang Y
J Gastrointest Surg; 2021 Jan; 25(1):112-124. PubMed ID: 32128678
[TBL] [Abstract][Full Text] [Related]
16. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract][Full Text] [Related]
17. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
Zang Y; Long P; Wang M; Huang S; Chen C
Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
[No Abstract] [Full Text] [Related]
19. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients.
Liu K; Huang G; Chang P; Zhang W; Li T; Dai Z; Lv Y
Sci Rep; 2020 Dec; 10(1):21376. PubMed ID: 33288828
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of preoperative and postoperative peripheral lymphocyte difference in hepatitis B virus-related hepatocellular cancer patients: Based on the analysis of dynamic nomogram.
Luo D; Li H; Yu H; Zhang M; Hu J; Jin C; Chua M; Han B
J Surg Oncol; 2020 Dec; 122(8):1553-1568. PubMed ID: 32862430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]